Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor

Clinical trial NCT05905887 · RECRUITING

Trial details

NCT number: NCT05905887
Sponsor: Asan Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2023-09-06
Primary completion: 2027-08-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.